We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Tick-Borne Diseases Diagnosed with Multiplex Molecular Panel

By LabMedica International staff writers
Posted on 26 Dec 2018
Tick-borne diseases, which afflict humans and other animals, are caused by infectious agents transmitted by tick bites. More...
Tick-borne illnesses are caused by infection with a variety of pathogens, including rickettsia and other types of bacteria, viruses, and protozoa.

Although Lyme disease is the most prevalent tick-borne infection in the USA, experts are seeing more serious tick-borne illnesses, some of them fatal if not treated right away. It’s difficult to predict from year to year how many cases of tick-borne diseases will be reported in the USA. The tiny arachnids are now in 50 states, and as a result, more people are at risk every spring, summer, and fall.

ChromaCode Inc (Carlsbad, CA, USA) has launched a nine-target, quantitative polymerase chain reaction (qPCR) panel test that can detect a total of 12 species that are typically transmitted to humans by ticks in various regions of the USA. The core technology, called high-definition PCR (HDPCR), enables standard thermal cyclers to run multiplexed panel tests. Essentially, it modifies standard TaqMan chemistry to create unique curve signatures depending on the targets present, with specialized, user-friendly, cloud-based software to deconvolve and interpret the curves.

The test detects a total of nine DNA targets from bacteria and protozoa carried by ticks that bite people, but two of those targets can pick up multiple species. The bacterial targets include Anaplasma phagocytophilum, which is the cause of anaplasmosis, three species of Ehrlichia: Ehrlichia chaffeensis, Ehrlichia ewingii, Ehrilicha muris eauclarensis and Rickettsia species that are known to cause Rocky Mountain Spotted Fever. The test also detects a few of the most common Borrelia species, a type of spirochete bacteria that is the cause of Lyme disease. Specifically, it detects Borrelia miyamotoi, as well as a target the firm calls Borrelia Group #1, which includes B. burgdorferi and the newly-discovered B. mayonii, and a target called Borrelia Group #2 that detects B. hermsii, B. parkeri, and B. turicatae. The test also detects DNA of one tick-borne protozoa, Babesia microti that is the cause of Babesiosis, an infection most common in the Northeast.

Blake Buchan, PhD, a pathologist at the Medical College of Wisconsin (Milwaukee, WI, USA) evaluated panel to test 175 prospectively collected samples from patients suspected of having Lyme disease, as well as 20 retrospective samples from known positive cases, 93 simulated specimens, and samples collected locally as well as ones from a more rural part of Northern Wisconsin. Overall, the evaluation found 19 clinical samples tested positive, and all had one of three targets, namely the A. phagocytophilum, B. microti, or B. miyamotoi. Compared to singleplex PCR testing, the latter two targets showed 100% sensitivity and specificity, while the former had 100% specificity and 91% sensitivity. There were two false-positive results, one for E. muris eauclarensis and one for the Rickettsia species target, which were retrospective clinical samples positive for A. phagocytophilum. The panel also uncovered two cases in which the pathogens that were detected were things the clinicians would not otherwise have tested for. The results were presented at the Association for Molecular Pathology meeting held November 1-3, 2018, San Antonio, TX, USA.

Related Links:
ChromaCode
Medical College of Wisconsin


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
New
Integrated Biochemical & Immunological System
Biolumi CX8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.